- Home
- GTX vs APGE Comparison
GTX vs APGE Comparison
Compare GTX & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTX
- APGE
- Stock Information
- Founded
- GTX 2018
- APGE 2022
- Country
- GTX Switzerland
- APGE United States
- Employees
- GTX N/A
- APGE N/A
- Industry
- GTX Auto Parts:O.E.M.
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GTX Consumer Discretionary
- APGE Health Care
- Exchange
- GTX Nasdaq
- APGE Nasdaq
- Market Cap
- GTX 1.8B
- APGE 2.1B
- IPO Year
- GTX N/A
- APGE 2023
- Fundamental
- Price
- GTX $9.02
- APGE $33.11
- Analyst Decision
- GTX Strong Buy
- APGE Strong Buy
- Analyst Count
- GTX 1
- APGE 4
- Target Price
- GTX $12.00
- APGE $91.33
- AVG Volume (30 Days)
- GTX 2.0M
- APGE 802.7K
- Earning Date
- GTX 05-01-2025
- APGE 05-12-2025
- Dividend Yield
- GTX 0.67%
- APGE N/A
- EPS Growth
- GTX N/A
- APGE N/A
- EPS
- GTX 1.26
- APGE N/A
- Revenue
- GTX $3,475,000,000.00
- APGE N/A
- Revenue This Year
- GTX N/A
- APGE N/A
- Revenue Next Year
- GTX $7.85
- APGE $743.14
- P/E Ratio
- GTX $7.16
- APGE N/A
- Revenue Growth
- GTX N/A
- APGE N/A
- 52 Week Low
- GTX $7.02
- APGE $26.20
- 52 Week High
- GTX $10.39
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- GTX 55.97
- APGE 45.63
- Support Level
- GTX $8.84
- APGE $31.38
- Resistance Level
- GTX $9.22
- APGE $34.23
- Average True Range (ATR)
- GTX 0.46
- APGE 3.28
- MACD
- GTX 0.14
- APGE -0.18
- Stochastic Oscillator
- GTX 91.14
- APGE 54.22
About GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.